Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep;56(5):898-899.
doi: 10.1111/apt.17140.

Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with inflammatory bowel disease-authors' reply

Konstantina Rosiou  1 , Christian P Selinger  1
Affiliations
Editorial

Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with inflammatory bowel disease-authors' reply

Konstantina Rosiou et al. Aliment Pharmacol Ther. 2022 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Haydek JP, Scott FI. Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with IBD. Aliment Pharmacol Ther. 2022;56:896-897.
    1. Dorrington AM, Selinger CP, Parkes GC, Smith M, Pollok RC, Raine T. The historical role and contemporary use of corticosteroids in inflammatory bowel disease. J Crohns Colitis. 2020;14(9):1316-29.
    1. Rosiou K, Carbonell J, Dolby V, Monfared N, Raine T, Selinger CP. Sources of excess steroid prescriptions and clinical adverse outcomes associated with steroid excess in patients with inflammatory bowel disease: the Leeds IBD steroids study. Aliment Pharmacol Ther. 2022;56:501-509.
    1. Selinger CP, Parkes GC, Bassi A, Fogden E, Hayee B, Limdi JK, et al. A multi-centre audit of excess steroid use in 1176 patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46:964-973.
    1. Selinger CP, Parkes GC, Bassi A, Limdi JK, Ludlow H, Patel P, et al. Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients. Aliment Pharmacol Ther. 2019;50:1009-1018.

MeSH terms

Substances